IHS Chemical Week

People & Business :: M&A

Pfizer to Acquire King Pharmaceuticals for $3.6 Billion

1:06 AM MDT | October 13, 2010 | Deepti Ramesh

Pfizer says it has entered into a definitive agreement to acquire specialty pharmaceutical company King Pharmaceuticals (Bristol, TN) for $3.6 billion in cash, or $14.25/share, which represents a premium of about 40% to King's closing price on October 11. The acquisition is expected to be completed in the fourth quarter of 2010 or the first quarter of 2011. The acquisition will expand Pfizer's business profile, providing incremental diversified revenues generated by King's portfolio, including a prescription pharmaceutical business focused on formulations of pain...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa